– Bloomberg
Related Posts
Clover Health Investments Q2 Sales $412.50M Beat $205.38M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $412.50 million which beat the analyst consensus estimate of $205.38 million by 100.85 percent.
Jim Cramer Says He’s Known Novavax Is ‘Worthless’ For ‘Very Long Time,’ Trashes Company For Being Too ‘Promotional’
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue.
Jim Cramer isn't surprised.